1. Introduction

1.1 Colorectal Cancer
1.2 Diagnosis
1.3 Treatment


2. Market Overview

2.1 Global Colorectal Cancer Incidences Forecast
2.2 CRC Death Averted per 1,000 Individuals Screened
2.3 Distribution of Colorectal Cases and Relative Survival
2.4 Colorectal Cancer Screening Test Types


3. The U.S. Colorectal Cancer Screening Market

3.1 The U.S. CRC Screening Eligible Patient Volume Forecast
3.2 The U.S. CRC Screening Receiving Patient Volume Forecast
3.3 The U.S. CRC Screening Test Market Volume Forecast
3.4 The U.S. CRC Screening Market Volume by Type
3.4.1 The U.S. CRC Colonoscopies Volume Forecast
3.4.2 The U.S. CRC Sigmoidoscopies Volume Forecast
3.4.3 The U.S. CRC FOBT Volume Forecast
3.4.4 The U.S. CRC Stool Based DNA Test Volume Forecast
3.5 The U.S. CRC Screening Test Product Market
3.5.1 The U.S. CRC Frontline Screening Tested Patient Volume Forecast
3.5.2 The U.S. CRC Frontline Screening Test Sales Forecast by Value
3.5.3 The U.S. CRC Cologuard Screening Test Sales Forecast
3.5.4 The U.S. CRC Epi proColon Screening Test Sales Value Forecast


4. Europe Colorectal Cancer Screening Market

4.1 Europe CRC Screening Eligible Patient Volume Forecast
4.2 Europe CRC Screening Eligible Patient Volume by Country
4.2.1 The UK CRC Screening Eligible Patient Volume Forecast
4.2.2 Sweden CRC Screening Eligible Patient Volume Forecast
4.2.3 Denmark CRC Screening Eligible Patient Volume Forecast
4.2.4 Netherland CRC Screening Eligible Patient Volume Forecast
4.3 Europe CRC Screening Receiving Patient Volume Forecast
4.4 Europe CRC Screening Test Product Market
4.4.1 Europe CRC Frontline Screening Tested Patient Volume Forecast
4.4.2 Europe CRC Frontline Screening Test Sales Forecast by Value
4.4.3 Europe CRC Triage Screening Tested Patient Volume Forecast
4.4.4 Europe CRC Triage Screening Test Sales Forecast by Value


5. Asia Colorectal Cancer Screening Market

5.1 Asia CRC Screening Eligible Patient Volume Forecast
5.2 Asia CRC Screening Test Product Market
5.2.1 Asia CRC Frontline Screening Tested Patient Volume Forecast
5.2.2 Asia CRC Frontline Screening Test Sales Forecast by Value
5.2.3 Asia CRC Triage Screening Test Sales Forecast by Value
5.2.4 Asia CRC Triage Screening Tested Patient Volume Forecast


6. Market Dynamics

6.1 Growth Drivers
6.1.1 Increasing Disposable Income
6.1.2 Acceleration of Ageing Population and Cancer Incident Cases
6.1.3 Rising Healthcare Expenditure

6.2 Key Trends
6.2.1 Launch of Branded and Advanced Diagnostic Tests
6.2.2 Technology Innovation

6.3 Challenges
6.3.1 Stringent Legal Norms
6.3.2 High Cost and Alternative Treatments
6.3.3 Need for High Quality of Screening Process
6.3.4 Dearth of Expertise


7. Competition

7.1 Global Market
7.1.1 Revenue Comparison of Key Players
7.1.3 DNA based CRC Screening Tests Comparison


8. Company Profiles

8.1 Exact Sciences Corporation
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategies

8.2 Volition Rx Ltd.
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategies

8.3 Epigenomics AG
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategies

8.4 Quest Diagnostics
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategies